DKK1 and adenoma: Data quantification across the series revealed absence of nuclear DKK-1 in 22% of adenomas and 75% of carcinomas, and a loss of DKK-1 expression during tumor progression that occurred earlier in the nucleus than in the cytoplasm (Fig. 3B).